NMDA receptor antibodies are found in a small subgroup of patients with first-episode psychosis, but their clinical relevance is unknown

2017 ◽  
Vol 21 (1) ◽  
pp. e1.2-e2 ◽  
Author(s):  
Morten Schou ◽  
Sverre Georg Saether
2015 ◽  
Vol 30 ◽  
pp. 1568 ◽  
Author(s):  
E. Kelleher ◽  
P. McNamara ◽  
B. Fitzmaurice ◽  
R. Walsh ◽  
Y. Langan ◽  
...  

2014 ◽  
Vol 153 ◽  
pp. S35 ◽  
Author(s):  
Belinda Lennox ◽  
Michael S. Zandi ◽  
Julia B. Deakin ◽  
Alasdair Coles ◽  
Linda Scoriels ◽  
...  

2020 ◽  
Vol 28 (2) ◽  
pp. 199-201
Author(s):  
Joel Singer ◽  
Perminder Sachdev ◽  
Adith Mohan

Objective: The current guidelines recommend screening all patients with first episode psychosis (FEP) for anti-NMDA receptor encephalitis. This paper explores the pitfalls of this strategy. Conclusion: Screening for anti-NMDA receptor encephalitis in patients with FEP when the pre-test probability based on the clinical presentation is low creates a risk of false positive results. Testing based on clinical suspicion would be preferable.


2019 ◽  
Vol 29 ◽  
pp. S68
Author(s):  
C. Loureiro ◽  
H.A. Fachim ◽  
F. Corsi-Zuelli ◽  
P.R. Menezes ◽  
C.F. Dalton ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document